Comparison of the in vitro and in vivo stability of a succinimide intermediate observed on a therapeutic IgG1 molecule
Open Access
- 1 May 2013
- journal article
- research article
- Published by Taylor & Francis in mAbs
- Vol. 5 (3) , 432-444
Abstract
Deamidation of asparagine residues, a post-translational modification observed in proteins, is a common degradation pathway in monoclonal antibodies (mAbs). The kinetics of deamidation is influenced by primary sequence as well as secondary and tertiary folding. Analytical hydrophobic interaction chromatography (HIC) is used to evaluate hydrophobicity of candidate mAbs and uncover post-translational modifications. Using HIC, we discovered atypical heterogeneity in a highly hydrophobic molecule (mAb-1). Characterization of the different HIC fractions using LC/MS/MS revealed a stable succinimide intermediate species localized to an asparagine-glycine motif in the heavy chain binding region. The succinimide intermediate was stable in vitro at pH 7 and below and increased on storage at 25°C and 40°C. Biacore evaluation showed a decrease in binding affinity of the succinimide intermediate compared with the native asparagine molecule. In vivo studies of mAb-1 recovered from a pharmacokinetic study in cynomolgus monkeys revealed an unstable succinimide species and rapid conversion to aspartic/iso-aspartic acid. Mutation from asparagine to aspartic acid led to little loss in affinity. This study illustrates the importance of evaluating modifications of therapeutic mAbs both in vitro and in serum, the intended environment of the molecule. Potential mechanisms that stabilize the succinimide intermediate in vitro are discussed.Keywords
This publication has 43 references indexed in Scilit:
- World Bispecific Antibody Summit, September 27–28, 2011, Boston, MAmAbs, 2012
- Which are the antibodies to watch in 2012?mAbs, 2012
- Accurate Determination of Succinimide Degradation Products Using High Fidelity Trypsin Digestion Peptide Map AnalysisAnalytical Chemistry, 2011
- Taylor Dispersion Analysis Compared to Dynamic Light Scattering for the Size Analysis of Therapeutic Peptides and Proteins and Their AggregatesPharmaceutical Research, 2011
- HIC resolution of an IgG1 with an oxidized Trp in a complementarity determining regionJournal of Chromatography B, 2011
- Identification of isomerization and racemization of aspartate in the Asp–Asp motifs of a therapeutic proteinAnalytical Biochemistry, 2011
- Formulation Development of Antibodies Using Robotic System and High-Throughput Laboratory (HTL)Journal of Pharmaceutical Sciences, 2010
- Direct Identification and Quantification of Aspartyl Succinimide in an IgG2 mAb by RapiGest Assisted DigestionAnalytical Chemistry, 2009
- Altered immunogenicity of isoaspartate containing proteinsAutoimmunity, 2007
- Isoaspartyl Post-translational Modification Triggers Anti-tumor T and B Lymphocyte ImmunityJournal of Biological Chemistry, 2006